New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Clever Leaves Holdings Inc.
CLVR
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

526

Drug Manufacturers - Specialty & Generic

Next Earning date - 28 Oct 2024

526

Drug Manufacturers - Specialty & Generic

Next Earning date - 28 Oct 2024

0.00USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

11
favorite-chart

Volume Buzz

-50%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

100%

Quote Panel

Shape
Updated October 28, 2024
1W 0.00 % 1M 0.00 % 3M -99.99 % 1Y -99.99 %

Key Metrics

Shape
  • Market Cap

    526


  • Shares Outstanding

    1.75M


  • Share in Float

    1.64M


  • Dividende

    0


  • Earning Date

    28 Oct 2024


  • Price Target

    0.0003


  • Average Volume

    202


  • Beta

    15.078


  • Range

    1.0E-4-5.8899


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.cleverleaves.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.00x

P/B Ratio

0.1

Debt/Equity

-81.5%

Net Margin

$-12.6

EPS

How CLVR compares to sector?

P/E Ratio

Relative Strength

Shape

CLVR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$105M

Shape249%

2025-Revenue

$13.80

Shape309%

2025-EPS

$99M

Shape-249%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cantor Fitzgerald

initialise

Previous: Not converted

2022-08-01

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-15.62
vs -10.81

Q2.22

arrow
arrow

N/A

-6.01
vs -12.01

Q3.22

arrow
arrow

N/A

-5.71
vs -13.21

Q4.22

arrow
arrow

N/A

-3.90
vs -5.11

Q1.23

arrow
arrow

N/A

-2.70
vs -15.62

Q2.23

arrow
arrow

N/A

-2.10
vs -6.01

Q3.23

arrow
arrow

N/A

-4.60
vs -5.71

Q4.23

arrow
arrow

N/A

-1.29
vs -3.90

Q1.24

arrow
arrow

+158%

1.58
vs -2.70

Q2.24

arrow
arrow

+164%

1.34
vs -2.10

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

+50%

5.2M  vs 3.5M

Q2.22

arrow
arrow

+12%

4.1M  vs 3.7M

Q3.22

arrow
arrow

-29%

2.9M  vs 4M

Q4.22

arrow
arrow

+10%

4.6M  vs 4.2M

Q1.23

arrow
arrow

-24%

4M  vs 5.2M

Q2.23

arrow
arrow

+21%

5M  vs 4.1M

Q3.23

arrow
arrow

+33%

3.8M  vs 2.9M

Q4.23

arrow
arrow

+1%

4.6M  vs 4.6M

Q1.24

arrow
arrow

+23%

4.9M  vs 4M

Q2.24

arrow
arrow

+4%

5.2M  vs 5M

Return on EquityShape

status-upQoQ

Q1.22

arrow
arrow

-30%

-0.30
vs -0.33

Q2.22

arrow
arrow

-1%

-0.01
vs -0.30

Q3.22

arrow
arrow

-29%

-0.29
vs -0.01

Q4.22

arrow
arrow

-71%

-0.71
vs -0.29

Q1.23

arrow
arrow

-11%

-0.11
vs -0.71

Q2.23

arrow
arrow

-11%

-0.11
vs -0.11

Q3.23

arrow
arrow

-17%

-0.17
vs -0.11

Q4.23

arrow
arrow

-9%

-0.09
vs -0.17

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

46

46
vs 36

28%

Q4.21

arrow
arrow

50

50
vs 46

9%

Q1.22

arrow
arrow

51

51
vs 50

2%

Q2.22

arrow
arrow

43

43
vs 51

-16%

Q3.22

arrow
arrow

38

38
vs 43

-12%

Q4.22

arrow
arrow

39

39
vs 38

3%

Q1.23

arrow
arrow

31

31
vs 39

-21%

Q2.23

arrow
arrow

31

31
vs 31

NA

Earnings Growth

Latest News